Fifteen years of qualification
Audited Supplier
In This Store
Dongbao Enterprise Group Co. Ltd. is a leading biopharmaceutical company actively engaged in R&D, production and marketing of high-quality biological products. As one of the well-known manufacturer of RH insulin, in the segment of diabetes mellitus, we have also developed glargine, aspart, lispro and degludec, as well as liraglutide and delaglutide. In Dongbao’s biotech portfolio, different monoclonal antibodies (adalimumab, etanercept and rituximab), recombinant human albumin and recombinant coagulation factor VII & VIII are also well developed.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094
Pharma Sources Insight July 2025
